SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-24-000223
Filing Date
2024-01-17
Accepted
2024-01-16 20:39:45
Documents
56
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ivbt_10k.htm   iXBRL 10-K 1096829
2 CERTIFICATION ivbt_ex311.htm EX-31.1 12821
3 CERTIFICATION ivbt_ex321.htm EX-32.1 5790
9 ivbt_10kimg3.jpg GRAPHIC 2995
10 ivbt_10kimg4.jpg GRAPHIC 4594
  Complete submission text file 0001477932-24-000223.txt   4437779

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ivbt-20230831.xsd EX-101.SCH 46514
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivbt-20230831_lab.xml EX-101.LAB 284260
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ivbt-20230831_cal.xml EX-101.CAL 47846
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivbt-20230831_pre.xml EX-101.PRE 232660
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ivbt-20230831_def.xml EX-101.DEF 135985
50 EXTRACTED XBRL INSTANCE DOCUMENT ivbt_10k_htm.xml XML 485754
Mailing Address 179 RTE 46W, SUITE 15 #147 ROCKAWAY NJ 07866
Business Address 179 RTE 46W, SUITE 15 #147 ROCKAWAY NJ 07866 929-459-4966
Innovation1 Biotech Inc. (Filer) CIK: 0001629205 (see all company filings)

IRS No.: 822275255 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-55852 | Film No.: 24536551
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)